Conversely, EPN3 ectopic overexpression in not-amplified/overexpressing BC cells (i.e., HCC1569) increased their in vivo tumorigenic potential (Supplementary Fig. 2E), arguing that EPN3 overexpression might be an advantage-conferring event in BC. The gene discussed is EPN3; the disease is breast cancer.